Northrop Grumman Corporation (NOC)
NYSE: NOC · Real-Time Price · USD
575.11
-12.55 (-2.14%)
At close: Apr 24, 2026, 4:00 PM EDT
576.00
+0.89 (0.15%)
After-hours: Apr 24, 2026, 7:59 PM EDT

Northrop Grumman Earnings Call Transcripts

Fiscal Year 2026

Fiscal Year 2025

  • Record backlog and strong sales growth in 2025, with free cash flow up 26% year-over-year. 2026 guidance calls for mid-single-digit sales growth, continued margin expansion, and increased capital investment, with momentum expected to accelerate into 2027.

  • Strong demand and acquisition reform are driving growth, with a $90B+ backlog and double-digit international expansion. Margin and free cash flow improvements are supported by digital transformation, portfolio balance, and strategic capital deployment.

  • Q3 saw strong sales, margin, and cash flow growth, with robust program execution and international demand. Guidance for 2025 was revised down due to award delays, but 2026 outlook remains positive with balanced segment growth and continued investment in innovation.

  • Heightened global defense demand is driving growth, with strong U.S. and international funding for modernization and recapitalization. Key programs like B-21, Sentinel, and Golden Dome are accelerating, while international business and partnerships are expanding, supporting margin growth and innovation.

  • Q2 saw strong revenue, margin, and EPS growth, with all segments contributing and international sales up 18% year-over-year. Guidance for operating income, EPS, and free cash flow was raised, supported by robust demand, major program funding, and continued capital returns to shareholders.

  • Backlog and international demand remain strong, with double-digit international growth expected through the decade. Key programs like B-21, Sentinel, and IBCS drive long-term growth, while disciplined investment and portfolio management support robust cash flow and shareholder returns.

  • AGM 2025

    The meeting covered strong financial results, a record backlog, and increased dividends. All board nominees were elected, executive compensation and auditor ratification passed, while a shareholder proposal to strengthen the clawback policy was rejected.

  • Q1 sales declined 7% year-over-year to $9.5B, impacted by B-21 program charges and contracting delays, but record backlog and strong international growth support reaffirmed 2025 sales and cash flow guidance. The $477M B-21 loss was driven by process and material cost changes.

  • National security priorities and defense spending are driving robust growth, with international demand outpacing domestic. Efficiency, digital transformation, and partnerships with new entrants are key to innovation and cost reduction. Technology leadership and a diversified portfolio support long-term optimism.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Fiscal Year 2020

Fiscal Year 2019

Powered by